226
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study

, , , , &
Pages 1-10 | Accepted 12 Oct 2007, Published online: 16 Nov 2007

References

  • Youngstrom EA, Gracious BL, Danielson CK, et al. Toward an integration of parent and clinician report on the Young Mania Rating Scale. J Affect Disord 2003;77:179–90
  • Chengappa KN, Baker RW, Shao L, et al. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord 2003;5:1–5
  • Patel NC, Patrick DM, Youngstrom EA, et al. Response and remission in adolescent mania: signal detection analyses of the young mania rating scale. J Am Acad Child Adolesc Psychiatry 2007;46:628–35
  • Canuso C, Zhu Y, Bossie C, Grossman F. Remission with risperidone in combination with mood stabilizers in acute bipolar mania (abstract P35). Bipolar Disord 2003;5:38
  • Sachs G, Chengappa KN, Suppes T, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004;6:213–23
  • Yatham LN, Paulsson B, Mullen J, Vagero AM. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004;24:599–606 [errata in: J Clin Psychopharmacol 2005;25:201 and J Clin Psychopharmacol 2005;25: 103]
  • Yatham LN, Vieta E, Young AH, et al. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Int Clin Psychopharmacol 2007;22:212–20
  • Bowden CL, Grunze H, Mullen J, et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005;66:111–21
  • Sussman N, Mullen J, Paulsson B, et al. Rates of remission/ euthymia with quetiapine in combination with lithium/ divalproex for the treatment of acute mania. J Affect Disord 2007;100(Suppl 1):S55-S63 [epub 2007 March 26]
  • Ketter TA, Jones M, Paulsson B. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania. J Affect Disord 2007;100(Suppl 1):S45-S53 [epub 2007 March 26]
  • Pae CU, Kim TS, Kim JJ, et al. Long-term treatment of adjunctive quetiapine for bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:763–6
  • Vieta E, Mullen J, Brecher M, et al. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomized, placebo-controlled studies. Curr Med Res Opin 2005;21:923–34
  • McIntyre RS, Brecher M, Paulsson B, et al. Quetiapine or haloperidol as monotherapy for bipolar mania – a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005;15:573–85 [epub 2005 April 18]
  • DelBello MP, Kowatch RA, Adler CM, et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006;45:305–13
  • Li KY, Li X, Cheng ZN, et al. Multiple dose pharmacokinetics of quetiapine and some of its metabolites in Chinese suffering from schizophrenia. Acta Pharmacol Sin 2004;25:390–4
  • Potkin SG, Thyrum PT, Bera R, et al. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Clin Ther 2002;24:1809–23
  • Nasrallah HA, Brecher M, Paulsson B. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disord 2006;8:467–74
  • Adler CM, Fleck DE, Brecher M, et al. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. J Affect Disord 2007;100(Suppl 1):S15-S22 [epub 2007 March 26]
  • Pae CU, Lee KU, Kim JJ, et al. Switching to quetiapine in patients with acute mania who were intolerant to risperidone. Hum Psychopharmacol 2004;19:47–51
  • Chen YF. Chinese classification of mental disorders (CCMD-3): towards integration in international classification. Psychopathology 2002;35:171–5
  • Tobias LL, MacDonald ML. Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review. Psychol Bull 1974;81:107–25
  • Niufan G, Tohen M, Qiuqing A, et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. J Affect Disord 2007 [epub ahead of print]
  • Khanna S, Vieta E, Lyons B, et al. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 2005;187:229–34
  • Goldberg JF, Kelley ME, Rosenquist KJ, et al. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. J Affect Disord 2007 [epub ahead of print]
  • Kim DJ, Lyoo IK, Yoon SJ, et al. Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1182–8
  • Stratta P, de Cataldo S, Mancini G, et al. Quetiapine as adjunctive treatment of a case of rapid-cycling bipolar disorder with comorbidity. Hum Psychopharmacol 2003;18:559–60
  • Vieta E, Parramon G, Padrell E, et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 2002;4:335–40
  • Li KY, Li X, Cheng ZN, et al. Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia. Eur J Clin Pharmacol. 2005;60:791–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.